@article{36dbd43493824c1ab79b04ecf2b75e12,
title = "Tonabersat for migraine prevention: new life or last gasp?",
author = "Dodick, {David W.}",
note = "Funding Information: DWD receives research funding from Medtronic, Advanced Neurostimulations Systems, St Jude, US National Institute of Neurological Disorders and Stroke, and Mayo Clinic. He is a consultant or has received consulting honoraria from Allergan, Addex, Alexza, Almirrall, Coherex, Eli Lilly, Endo, GlaxoSmithKline, HS Lundbeck Kowa, MAP, Medtronic, Merck, Minster Pharmaceuticals, Neuralieve, Neuraxon, Novartis, NuPathe, and Pfizer. Copyright: Copyright 2009 Elsevier B.V., All rights reserved.",
year = "2009",
month = aug,
doi = "10.1016/S1474-4422(09)70174-7",
language = "English (US)",
volume = "8",
pages = "693--695",
journal = "The Lancet Neurology",
issn = "1474-4422",
publisher = "Lancet Publishing Group",
number = "8",
}